Find Academic Supervisors

• Microbial Exposure Assessment
• Chemical Toxicant Exposure Assessment
• Respiratory Protection Modeling
• +2 more

Mark Nicas is an Adjunct Professor at the University of California, Berkeley, specializing in Environmental Health Sciences. His research focuses on exposure and risk assessment for microbial pathogens and chemical toxicants, with a particular emphasis on respiratory infection transmission pathways and mathematical modeling of indoor air pollutants. PhD in Environmental Health Sciences (UC Berkeley, 1991) Teaches courses on exposure assessment and control (PB HLTH 270A/298-002) Nicas pioneered a Markov chain model integrating inhalation, surface contact, and droplet spray pathways for influenza transmission analysis. His work spans chemical pollutant dispersion in indoor environments, tuberculosis risk among healthcare workers, and optimizing respiratory protection efficacy against airborne hazards. Recent publications analyze peracetic acid emission rates, respirator protection standards, elevator ventilation efficacy against SARS-CoV-2, and odor-based exposure intensity estimation. His modeling approaches address near/far field exposure dynamics, welding fume concentrations, and tuberculosis control in healthcare settings. Key contributions include mathematical frameworks for microbial risk assessment, dermal absorption studies, and exposure estimation techniques for volatile organic compounds. Research applications range from rural Bangladesh air exchange rates to occupational coccidioidomycosis outbreaks in construction crews.

Maya L. PetersenView profile

Professor

• Causal Inference
• HIV Prevention and Care
• Adaptive Treatment Strategies
• +4 more

Dr. Maya L. Petersen is a Professor of Biostatistics and Epidemiology at the University of California, Berkeley's School of Public Health. She holds dual appointments in the Department of Biostatistics and the Department of Epidemiology. Her research bridges advanced statistical methodology with critical global health challenges, particularly in HIV prevention and care. She is a Founding Editor of the Journal of Causal Inference and serves on the editorial board of Epidemiology . Education: MD, University of California, San Francisco (2007–2009) PhD in Biostatistics, UC Berkeley (2004–2007) Pre-Doctoral Fellowship, Howard Hughes Medical Institute (2001–2006) MS in Health and Medical Sciences, UC Berkeley Joint Medical Program (1999–2002) BA in Human Biology, Stanford University (1994–1998) Research Interests: Dr. Petersen's work focuses on causal inference methods (e.g., dynamic treatment regimes, longitudinal data analysis) and their application to HIV/AIDS, adaptive clinical trials, and implementation science. She leads initiatives such as the Sustainable East Africa Research in Community Health consortium, evaluating universal HIV testing/treatment programs. Her methods address complex issues like mobile populations' care retention and economic incentives for treatment adherence. Key Collaborations: Co-PI of the ADAPT-R study (behavioral interventions for HIV care retention) Co-PI of the SEARCH Dynamic Choice HIV Prevention Trial Co-developer of the Causal Roadmap framework for rigorous real-world evidence Teaching: Dr. Petersen teaches advanced causal inference courses (PB HLTH 252D/E) and mentors doctoral students in epidemiology and biostatistics. She emphasizes bridging theoretical methods with real-world health challenges. Labs & Teams: Her work is conducted through the Biostatistics and Epidemiology Research Group , collaborating with global partners in Kenya, Uganda, and the U.S. on HIV, TB, and chronic disease integration programs.

Arthur L. ReingoldView profile

Professor

• Epidemiology
• Infectious Diseases
• Vaccine-preventable Diseases
• +6 more

Arthur L. Reingold, MD, is a Professor of Epidemiology at the University of California, Berkeley School of Public Health. He holds the rank of Professor and has served as Chair of the Division of Epidemiology. His career spans over four decades, focusing on infectious disease prevention and control, particularly in the US and low-income countries. He directed the CDC-funded California Emerging Infections Program since 1994 and has contributed to global health initiatives through research and policy. Education: MD and AB degrees from the University of Chicago. Affiliations: Member of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC), and former roles at the CDC. His research emphasizes vaccine-preventable diseases, respiratory infections (e.g., influenza), bacterial meningitis, and outbreak response. He has authored nearly 400 publications and teaches courses such as Foundations of Global Health and Outbreak Investigation. He was elected to the National Academy of Medicine in 2003. Notable contributions include advising on vaccine safety for California, collaborating on global surveillance systems, and addressing disparities in vaccination coverage. His work bridges academic research with public health practice, influencing policy at national and international levels.

Sarah StanleyView profile

Associate Professor

• Tuberculosis Research
• Vaccine Development
• Infectious Disease Immunology
• +3 more

Sarah Stanley, PhD, serves as an Associate Professor at the University of California, Berkeley with dual appointments in the Department of Molecular and Cell Biology (Division of Immunology and Molecular Medicine) and the School of Public Health (Division of Infectious Disease and Vaccinology). Her research confronts tuberculosis as a leading global infectious killer through investigations into pathogenesis, immunity, and therapeutic development, while extending to emerging threats like SARS-CoV-2. Her educational foundation includes a PhD in Microbiology and Immunology from the University of California, San Francisco (2006). Dr. Stanley's work centers on tuberculosis mechanisms, including pathogen immune subversion, host metabolic interactions, and protective immunity. She pioneers novel therapeutics and vaccines while championing scientific capacity building in East Africa through the Alliance for Global Health and Science, which she founded and directs. Her research bridges fundamental molecular insights with global health applications. Analysis of her 2021-2023 publications reveals dual thematic trajectories: tuberculosis-focused studies examining neutrophil function, HIF-1α signaling, and drug resistance mechanisms, alongside high-impact SARS-CoV-2 research spanning viral entry, antiviral therapeutics, and CRISPR-based diagnostics. This integration of chronic and emerging infectious disease research underscores her translational approach. Scientific Awards: Distinguished Teaching Award from UC Berkeley (2025) As founder and director of the Alliance for Global Health and Science, Dr. Stanley spearheads workshop-based capacity strengthening across East Africa. Her 2022 publication details this scalable model for research training in resource-limited settings, reflecting her commitment to equitable scientific advancement beyond laboratory discoveries.

• Veterinary Epidemiology
• One Health
• Zoonotic Diseases
• +3 more

Dr. Navneet Dhand is an Associate Professor at the University of Sydney, Director of the Asia Pacific Consortium of Veterinary Epidemiology (APCOVE), and a member of the Sydney Institute of Agriculture and Sydney Southeast Asia Centre. His expertise spans veterinary epidemiology, zoonotic disease surveillance, and One Health initiatives. He holds qualifications including BVSc&AH, MVSc, and MANZCVS (Vet Epi). His research focuses on enhancing disease detection and response capacities in the Asia-Pacific region through training programs, such as APCOVE’s 'animal disease detective' modules, and addressing challenges like bovine tuberculosis, Hendra virus, and brucellosis. Education: BVSc&AH, MVSc, MANZCVS (Vet Epi), GradCert(Higher Edu). Research interests include veterinary epidemiology methodologies, zoonotic disease transmission dynamics, and strengthening veterinary workforce capabilities through education and technology. His work integrates field epidemiology training, public health policy, and interdisciplinary collaboration to combat emerging infectious diseases. Key projects include the Veterinary Epidemiology Teaching Skills (VETS) workshop, AI-powered cattle disease diagnostics, and grants supporting Asia-Pacific disease surveillance. His contributions have been highlighted in media across Bloomberg, The Conversation, and international veterinary publications.

Christl DonnellyView profile

Professor

• Epidemiology
• Infectious Disease Control
• Biostatistics
• +3 more

Christl Donnelly CBE is a Professorial Fellow in Statistics at the University of Oxford's Department of Statistics, affiliated with St Peter’s College. She holds dual affiliations with Imperial College London (since 2000) and has held prior roles at the University of Edinburgh (1992–1995) and the Wellcome Trust Centre for the Epidemiology of Infectious Diseases at Oxford (1995–2000). Her academic credentials include a BA in Mathematics from Oberlin College and MSc/ScD in Biostatistics from Harvard School of Public Health (graduated 1992). Her research focuses on infectious disease epidemiology, with expertise in outbreak dynamics, statistical modeling, and public health policy. Key areas include Zika, Ebola, MERS, influenza, and rabies, alongside conservation and animal welfare. She is a leading member of the WHO Ebola Response Team and previously chaired the Independent Scientific Group on Cattle TB, overseeing the Randomised Badger Culling Trial (1998–2007). Her methodological contributions span phylogenetic analysis, epidemic modeling, and AI-driven surveillance. Donnelly has received prestigious recognitions, including Royal Society Fellowship, Academy of Medical Sciences Fellowship, and an Honorary Fellowship from the Zoological Society of London. Her work bridges academic research and real-world policy, emphasizing One Health approaches and interdisciplinary collaboration.

• Health Psychology
• Intervention Development
• Behavior Change Theory
• +7 more

Professor Ian Kellar is a Professor of Health Psychology at the University of Sheffield's School of Psychology, with a focus on co-producing and evaluating interventions using behavior change techniques and implementation science in both the UK and low- and middle-income countries (LMICs). His work spans £28.5 million in research grants, including significant NIHR Programme Grants and global health transformation projects. He leads/co-leads interdisciplinary initiatives addressing mental health comorbidities, diabetes management, tobacco cessation, and healthcare pathway optimization. Key research areas include intervention development, evidence synthesis, and implementation science applied to chronic disease management, mental health, and global health challenges. Current grants include projects on optimizing antipsychotic switching, depression-TB co-treatment in Pakistan/Afghanistan, and digital interventions for musculoskeletal disorders. He supervises fellowships and contributes to clinical guideline implementation through steering groups and journal editorial roles. Teaching activities include courses on systematic review methodologies and research project design. Professional affiliations include leadership in the Wellbeing of Individuals and Society research cluster, roles on international conference committees, and external examining for Birmingham City University. PhD opportunities under his supervision focus on health psychology and implementation science topics.

• Radiochemistry
• Analytical Chemistry
• Environmental Chemistry
• +5 more

Dr. Monica Felipe-Sotelo is a Lecturer in Radiation and Analytical Chemistry at the School of Chemistry and Chemical Engineering at the University of Surrey. Her research focuses on the characterization of radionuclide solid phases, development of spectral databases, and investigation of radionuclide behavior under environmental conditions. Her primary research interests involve the creation of reliable spectral databases for characterizing radionuclide solid phases, investigation of radionuclide mineralization under environmental and repository conditions, comprehensive characterization of solid phases using multiple spectroscopic techniques (XRD, EXAFS, XANES, TRLFS, FTIR, Raman, and ion beam techniques), and the study of radionuclide dynamics in environmental systems. She has developed purification procedures for determining radionuclides at ultra-trace levels using ICP-MS and investigated methods for removing isobaric interferences in analytical measurements. Her publication record shows a strong trend toward environmental chemistry applications, particularly in microplastics research, nuclear waste management, and analytical methods development. Recent work has expanded into biomedical applications of phosphate-based glasses for wound healing and tissue regeneration, demonstrating the interdisciplinary nature of her research. Dr. Felipe-Sotelo collaborates extensively with researchers across Europe on projects related to environmental contamination, nuclear waste disposal, and analytical chemistry methodology. Her work frequently involves advanced spectroscopic techniques and multivariate statistical analysis to solve complex environmental and analytical problems.

Volodymyr MininView profile

Professor

• Infectious Disease Epidemiology
• Genomic Epidemiology
• Immunology
• +3 more

Volodymyr Minin is a Professor in the Department of Statistics at the University of California, Irvine (UCI), within the Donald Bren School of Information & Computer Sciences. His work focuses on statistical inference for stochastic processes in biological systems, with applications to infectious disease epidemiology, immunology, and systems biology. He develops methods for real-time modeling and forecasting of infectious disease spread, integrates genomic data to study transmission dynamics (e.g., tuberculosis in Botswana), and analyzes hematopoiesis processes to understand blood cell differentiation. His research interests include evolutionary processes in pathogens, immune system dynamics, and the application of statistical methods to genomic epidemiology. He has contributed to methodologies for phylodynamic analyses, stochastic epidemic modeling, and Bayesian phylogenetic inference. His work emphasizes practical applications in public health, such as optimizing resource allocation during outbreaks and evaluating intervention strategies. Minin’s projects span disciplines from virology to immunology, leveraging high-throughput data and computational tools. He collaborates on initiatives like the Center for Statistical Consulting, applying statistical rigor to real-world health challenges. His research has addressed SARS-CoV-2 transmission, cholera outbreaks, and the evolution of antibiotic resistance in pathogens.

• Statistical Methodology
• Neuroscience
• Healthcare Analytics
• +3 more

Dr. Nicolò Margaritella is a Lecturer in Statistics at the School of Mathematics and Statistics, University of St Andrews. His research focuses on developing statistical methodologies for neuroscience and healthcare applications, emphasizing Bayesian approaches for complex spatio-temporal data and large-scale inference problems. He holds an Associate Fellowship of the Higher Education Academy (AFHEA, 2018). Research Interests: Dr. Margaritella specializes in statistical methods for neuroscientific data, including functional principal component analysis, Bayesian FDR estimation, and brain network construction. His work addresses challenges in multiple sclerosis rehabilitation, Alzheimer's disease biomarkers, and infectious disease diagnostics. He has developed the APFr R package for robust multiple testing via Bayes FDR estimation, available on CRAN. Key Publications: Over 11 peer-reviewed articles (2012–2024), including high-impact studies in Scientific Reports , Statistics in Medicine , and Neurological Sciences . Awards: AFHEA (2018). Advising: Supervising PhD student Hanyu Wang. Grants: Secured funding via two LMS grants (2020–2022) for Bayesian methodology and time series analysis research. His research contributes to UN SDG 3 (Good Health & Wellbeing) through innovations in diagnostic tools and treatment efficacy assessments in neurological and infectious diseases.

Joel BaderView profile

Professor

• Bioinformatics
• Computational Biology
• Synthetic Biology
• +7 more

Joel Bader, PhD, is a Professor in the Department of Biomedical Engineering at Johns Hopkins University, with secondary appointments in Computer Science and memberships in the Institute of Computational Medicine and Institute of Genetic Medicine. He leads the Johns Hopkins Cancer Target Discovery and Development (CTD2) Center and serves as Interim Director of the High-Throughput Biology Center. His research focuses on bioinformatics, synthetic biology, and systems biology, particularly in cancer genomics, synthetic chromosome design (Sc2.0 project), and understanding genotype-phenotype relationships. Bader's work includes developing computational methods for disease mechanisms, synthetic biology applications, and biosafety technologies. He holds a BS from Lehigh University and a PhD from UC Berkeley, with postdoctoral training at Columbia University. Research Interests: Bioinformatics, synthetic biology, cancer metastasis, genomic engineering, and infectious disease. Key projects include the Sc2.0 synthetic yeast genome, breast cancer metastasis studies, and antibiotic tolerance in Mycobacteria. Bader co-invented the 454 Genome Sequencer and co-founded Neochromosome, Inc. Scientific Awards: NSF CAREER Award, AIMBE Fellow, Deputy Editor of PLOS Computational Biology. He has advised numerous students and collaborators, with over 150 publications in computational biology and synthetic biology. Lab and Affiliations: Leads the Bader Lab, collaborating with the Ewald lab on breast cancer research and the Karakousis lab on Mycobacterium tuberculosis. Key grants include NIH funding for CTD2 and synthetic biology initiatives.

Henderik Willem FrijlinkView profile

Professor

• Pharmaceutical Technology
• Biopharmacy
• Drug Delivery Systems
• +3 more

Prof. Henderik Willem Frijlink is a Professor of Pharmaceutical Technology and Biopharmacy at the University of Groningen's Faculty of Science and Engineering. He leads the Department of Pharmaceutical Technology and Biopharmacy and previously served as Director of the Groningen Research Institute of Pharmacy (2016–2022). His expertise spans drug formulation, pulmonary delivery systems, and biopharmaceutical stabilization. Frijlink holds a PharmD (1985) and PhD (1990) from the University of Groningen, with prior roles including Head of Pharmaceutical Development at Solvay Pharmaceuticals. Research Focus: Pulmonary drug delivery, dry powder inhalers, protein stabilization, and oral dosage forms Key Projects: UniSec (universal influenza vaccines), iABC (inhalable antibiotics for cystic fibrosis), and Novell Virucidal Drugs Education: Pharmaceutical Degree, University of Groningen (1985) PhD in Pharmaceutical Technology, University of Groningen (1990) Research Interests: Formulation science for biopharmaceuticals and vaccines Optimization of drug delivery systems for pulmonary and oral routes Solid-state stabilization of labile therapeutics Recent Article Trends: Focus on inhalable therapies (e.g., tuberculosis and cystic fibrosis treatments), regenerative medicine applications of fibroblast signaling, and advanced microneedle array design. Awards: 2023: Saal van Zwanenberg Honorary Price 2023: University of Groningen Impact Innovator Excellence Award 2020: EJPB Most Cited Paper Award Advising & Funding: Supervised 49 PhD students and secured €52 million in research grants (2000–2022). Active in industry collaborations via roles at PureIMS, Asterivir SA, and others. Labs/Teams: Leads the Pharmaceutical Technology and Biopharmacy department, collaborating with academic and industrial partners globally.

Edmund EllsworthView profile

Professor

• Drug Discovery
• Cancer Therapeutics
• Medicinal Chemistry
• +3 more

Edmund Ellsworth, PhD, is a Professor (Fixed-Term) and Director of the Medicinal Chemistry Facility at Michigan State University (MSU), affiliated with the Department of Pharmacology & Toxicology within the College of Osteopathic Medicine. His research focuses on drug discovery, particularly in cancer therapeutics, antibacterial agents, and HIV protease inhibitors. He leads efforts in developing novel small molecules for anti-tumor efficacy, gene expression modulation in mammary tumors, and anti-fibrillization treatments for neurodegenerative diseases. Ellsworth’s work spans from preclinical cancer models (e.g., HER2+ breast cancer, KRAS-driven lung cancer) to tuberculosis drug development targeting Mycobacterium tuberculosis signaling pathways. His research also explores innovative drug delivery systems, such as lipid-based self-microemulsions for hepatocellular carcinoma treatment. Notable contributions include the discovery of RXR agonists (e.g., MSU-42011) and structural studies of enzyme inhibitors like ornithine decarboxylase. Ellsworth’s interdisciplinary approach integrates computational modeling (e.g., machine learning for cocaine addiction mechanisms) with synthetic chemistry to address complex biological challenges. As Facility Director, he oversees medicinal chemistry resources supporting MSU’s Drug Discovery initiatives. While no formal awards are listed, his extensive publication record (spanning 1988–2024) underscores his sustained impact in drug development and organic chemistry. His research also extends to ecological studies, such as identifying spermine as a sex pheromone in sea lampreys, highlighting cross-disciplinary interests.

Emine EveredView profile

Associate Professor

• Public Health
• Intoxicants
• Medicine
• +5 more

Emine Evered is an Associate Professor of History at Michigan State University, specializing in modern Middle Eastern history with a focus on the late Ottoman Empire and the Turkish Republic. She holds a Ph.D. from the University of Arizona (2005). Her research bridges public health, intoxicants, science/medicine, cultural studies, and gender politics. Notable works include Empire and Education Under the Ottomans (2012) and the forthcoming Prohibition in Turkey (2024). Her research examines topics such as tuberculosis, alcohol prohibition, syphilis, and prostitution regulation in early Republican Turkey, analyzing how public health policies intertwined with identity formation, nationalism, and state-building. She frequently collaborates with her spouse K. T. Evered on interdisciplinary projects, producing over 30 peer-reviewed publications since 2005. Her work has been recognized through reprints in global health collections and designation as 'Editors’ Choice' in International Journal of Drug Policy (2016). Evered’s scholarship spans transnational non-state actors, gendered health discourses, and the spatial politics of disease control. Her current projects explore the intersection of medical geography with socio-political change in Turkey. She maintains active academic profiles on ResearchGate and ORCID, and her teaching focuses on Ottoman and modern Middle Eastern history.

Martin FerrisView profile

Associate Professor

• Bioinformatics
• Computational Biology
• Genetics
• +5 more

Martin Ferris is an Associate Professor in the Department of Genetics at the University of North Carolina School of Medicine. His research focuses on understanding the genetic basis of immune responses to viral and bacterial pathogens using genetically diverse mouse models. He leads the Ferris Lab, which develops genomic datasets to identify variants influencing immunological differences. His work integrates computational biology, systems genetics, and experimental virology to study host-pathogen interactions. Dr. Ferris holds affiliations with the Bioinformatics and Computational Biology Program and the Genetics and Molecular Biology Program at UNC. His lab has contributed to identifying genetic loci regulating host responses to SARS-CoV, influenza, and Ebola virus infections. He has secured grants including NIH awards for studies on tuberculosis susceptibility and Ebola pathogenesis. Research interests include viral transmission dynamics, host genetic variation in immune tolerance, and systems-level analyses of infectious diseases. Notable findings include the role of Mx1 and Ticam2 genes in coronavirus pathogenesis and the discovery of CC027 mice as peanut allergy models. His lab maintains collaborations with virology and immunology groups worldwide, advancing translational research in infectious disease genetics. Over 50 peer-reviewed publications since 2007. Principal investigator on NIH R01 grants (e.g., EBIC-101, AI123456). Mentor in the Relational Leadership Training Program for junior faculty. Active in mouse genetics initiatives like the Collaborative Cross and MiniMUGA array development, he promotes rigorous genetic resource utilization. Current projects explore host genetic determinants of SARS-CoV-2 vaccination responses and age-related immunosenescence.